Hopkins Ranked #1 in Global Health
This year Johns Hopkins University was ranked #1 in global health by the Universities Allied for Essential Medicine's (UAEM) University Report Card on Global Equity & Biomedical Research. The 2015 report, released on April 21, showed the results of an evaluation of more than 50 top US universities based on their contributions to access to medicines and neglected biomedical research. These universities were assigned grades based on publicly-available and self-reported data concerning investment in research, promotion of equitable access, and education.
Hopkins was given high marks in all three evaluative categories: Access, Empowerment, and Innovation. You can read more about the questions addressed by each category here.
This ranking is reflective of the hard work of all our faculty, students, and affiliates.
The Global Reach of Johns Hopkins University
Johns Hopkins faculty, students, and staff are working across the globe. Across Johns Hopkins today:
- 34 centers and institutes are involved in global health programs
- 850 active global health projects are in progress in 100 countries involving more than 450 faculty members
- Travel is supported for at least 200 students per year from across the university
About UAEM & the Report Card
The UAEM Report Card is a product of intensive research and is meant to be an advocacy tool, urging universities to focus on neglected tropical diseases in sustainable ways. According to UAEM, universities can help save countless lives worldwide by increasing their focus on innovated neglected disease research and then sharing or licensing that research in globally accessible ways. In fact, between 1/4 and 1/3 of new medicines originate in academic labs, and universities have contributed to the development of one out of every four HIV/AIDS treatments (Kneller, 2010; Sampat, 2009). Universities have the knowledge and tools to break innovative ground in global health.
You can learn more about the UAEM Report Card Project in the video below:
|
Sources Kneller, Robert. "The importance of new companies for drug discovery: origins of a decade of new drugs." Nature Reviews Drug Discovery. 9, 867-882, November 2010 Sampat, Bhaven. "Academic Patents and Access to Medicines in Developing Countries." American Journal of Public Health. 2009 January; 99(1): 9-17. |